Omega Healthcare Investors, Inc. (NYSE:OHI) Stock Position Lifted by Van ECK Associates Corp

Van ECK Associates Corp raised its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 15.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 100,145 shares of the real estate investment trust's stock after acquiring an additional 13,367 shares during the period. Van ECK Associates Corp's holdings in Omega Healthcare Investors were worth $4,167,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Harbor Capital Advisors Inc. acquired a new position in Omega Healthcare Investors in the third quarter valued at approximately $53,000. Janney Montgomery Scott LLC raised its position in shares of Omega Healthcare Investors by 1.7% in the third quarter. Janney Montgomery Scott LLC now owns 31,493 shares of the real estate investment trust's stock valued at $1,282,000 after buying an additional 526 shares during the last quarter. Pure Financial Advisors LLC purchased a new position in shares of Omega Healthcare Investors in the third quarter worth about $218,000. Farther Finance Advisors LLC grew its stake in Omega Healthcare Investors by 141.5% during the 3rd quarter. Farther Finance Advisors LLC now owns 2,746 shares of the real estate investment trust's stock valued at $112,000 after acquiring an additional 1,609 shares in the last quarter. Finally, Focus Financial Network Inc. lifted its stake in Omega Healthcare Investors by 1.0% in the 3rd quarter. Focus Financial Network Inc. now owns 35,721 shares of the real estate investment trust's stock worth $1,454,000 after purchasing an additional 357 shares in the last quarter. 65.25% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have weighed in on OHI shares. Berenberg Bank began coverage on shares of Omega Healthcare Investors in a report on Friday, October 18th. They issued a "buy" rating and a $45.00 target price on the stock. Scotiabank upped their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "sector perform" rating in a research note on Monday, August 26th. Wells Fargo & Company reiterated an "overweight" rating and set a $43.00 target price (up previously from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. BNP Paribas raised Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 target price for the company in a research report on Thursday, October 31st. Finally, Mizuho downgraded Omega Healthcare Investors from an "outperform" rating to a "neutral" rating and increased their price objective for the company from $34.00 to $35.00 in a report on Thursday, July 25th. Six equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $39.70.

Insider Buying and Selling at Omega Healthcare Investors

In other news, COO Daniel J. Booth sold 56,725 shares of the business's stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the transaction, the chief operating officer now directly owns 100,000 shares of the company's stock, valued at $4,025,000. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Robert O. Stephenson sold 22,542 shares of the company's stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now directly owns 183,076 shares of the company's stock, valued at $7,357,824.44. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by insiders.

Omega Healthcare Investors Price Performance

Shares of OHI stock traded up $0.60 during midday trading on Friday, reaching $41.35. 1,509,533 shares of the company traded hands, compared to its average volume of 1,555,776. The firm has a market cap of $11.16 billion, a PE ratio of 30.40, a price-to-earnings-growth ratio of 1.27 and a beta of 0.99. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48. The firm's 50 day simple moving average is $40.59 and its two-hundred day simple moving average is $36.32. Omega Healthcare Investors, Inc. has a 1-year low of $27.53 and a 1-year high of $44.42.

Omega Healthcare Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Monday, November 4th will be paid a dividend of $0.67 per share. The ex-dividend date is Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.48%. Omega Healthcare Investors's dividend payout ratio (DPR) is 197.06%.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.